Søren Skjærbæk
Directeur Général chez Aloop Therapeutics ApS
Profil
Søren Sylvester Skjærbæk is currently the Co-Chief Executive Officer at Aloop Therapeutics ApS.
Previously, he worked as the Chief Executive Officer at NsGene A and as a Director at NRGi a.m.b.a.
Postes actifs de Søren Skjærbæk
| Sociétés | Poste | Début |
|---|---|---|
Aloop Therapeutics ApS
 Aloop Therapeutics ApS Pharmaceuticals: MajorHealth Technology Aloop Therapeutics ApS manufactures pharmaceutical preparations. The company is based in Copenhagen, Denmark. The CEOs are Søren Sylvester Skjærbæk, Thomas Kirkegaard Jensen. The Danish company was founded in 2022. | Directeur Général | - |
Anciens postes connus de Søren Skjærbæk
| Sociétés | Poste | Fin |
|---|---|---|
NRGi a.m.b.a.
 NRGi a.m.b.a. Electric UtilitiesUtilities NRGi a.m.b.a. provides solutions within infrastructure, energy, technology, construction, and communication. It focuses in the areas of electricity and heating; installation; product sales; consultancy; and renewable energy. The company was founded in 1915 and is headquartered in Aarhus, Denmark. | Directeur/Membre du Conseil | - |
NsGene A/S
 NsGene A/S Pharmaceuticals: MajorHealth Technology NsGene A/S identifies neurotrophic proteins with therapeutic effects in the nervous system. It is a biotechnology company that focuses primarily on neurodegenerative disorders. The firm provides technologies that target protein therapeutics across the blood-brain-barrier and directly to diseased nerve cells. It develops therapeutic products for multiple indications with high medical needs including Alzheimer’s disease, Parkinson's disease, deafness, neuropathic pain, epilepsy, cortico-basal degeneration, and Huntington’s disease. The company was founded by Lars Ulrik Wahlberg and Teit Eliot Johansen in 1999 and is headquartered in Ballerup, Denmark. | Directeur Général | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
NsGene A/S
NsGene A/S Pharmaceuticals: MajorHealth Technology NsGene A/S identifies neurotrophic proteins with therapeutic effects in the nervous system. It is a biotechnology company that focuses primarily on neurodegenerative disorders. The firm provides technologies that target protein therapeutics across the blood-brain-barrier and directly to diseased nerve cells. It develops therapeutic products for multiple indications with high medical needs including Alzheimer’s disease, Parkinson's disease, deafness, neuropathic pain, epilepsy, cortico-basal degeneration, and Huntington’s disease. The company was founded by Lars Ulrik Wahlberg and Teit Eliot Johansen in 1999 and is headquartered in Ballerup, Denmark. | Health Technology |
NRGi a.m.b.a.
NRGi a.m.b.a. Electric UtilitiesUtilities NRGi a.m.b.a. provides solutions within infrastructure, energy, technology, construction, and communication. It focuses in the areas of electricity and heating; installation; product sales; consultancy; and renewable energy. The company was founded in 1915 and is headquartered in Aarhus, Denmark. | Utilities |
Aloop Therapeutics ApS
Aloop Therapeutics ApS Pharmaceuticals: MajorHealth Technology Aloop Therapeutics ApS manufactures pharmaceutical preparations. The company is based in Copenhagen, Denmark. The CEOs are Søren Sylvester Skjærbæk, Thomas Kirkegaard Jensen. The Danish company was founded in 2022. | Health Technology |
